A novel visuospatial priming task for rats with relevance to Tourette syndrome and modulation of dopamine levels

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 6, 2013, Pages 1139-1149

  Amitai, Nurith ^a   Weber, Martin ^a,b   Swerdlow, Neal R ^a   Sharp, Richard F ^a   Breier, Michelle R ^a   Halberstadt, Adam L ^a   Young, Jared W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

Author keywords

Information processing; Negative priming; Rats; Tourette syndrome; Visuospatial priming

Indexed keywords

AMPHETAMINE; DOPAMINE;

BEHAVIOR CONTROL; BRAIN FUNCTION; DISEASE ASSOCIATION; DOPAMINERGIC TRANSMISSION; DOWN REGULATION; EXPERIMENTAL RAT; GILLES DE LA TOURETTE SYNDROME; LATENT PERIOD; NEGATIVE FEEDBACK; NEUROMODULATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE; STIMULUS RESPONSE; TASK PERFORMANCE; UPREGULATION; VISUOSPATIAL PRIMING TASK; ANIMAL; ATTENTION; COMPLICATION; DEPTH PERCEPTION; DISEASE MODEL; HUMAN; LONG EVANS RAT; MALE; METABOLISM; PHOTOSTIMULATION; PHYSIOLOGY; RAT; REACTION TIME; REPETITION PRIMING; TIME;

ANIMALS; ATTENTION; DISEASE MODELS, ANIMAL; DOPAMINE; HUMANS; MALE; PHOTIC STIMULATION; RATS; RATS, LONG-EVANS; REACTION TIME; REPETITION PRIMING; SPACE PERCEPTION; TIME FACTORS; TOURETTE SYNDROME;

EID: 84891896347     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2012.09.007     Document Type: Review

References (51)

1. Abraham N.M., Spors H., Carleton A., Margrie T.W., Kuner T., Schaefer A.T. Maintaining accuracy at the expense of speed: stimulus similarity defines odor discrimination time in mice. Neuron 2004, 44:865-876.
2. Albin R.L., Koeppe R.A., Bohnen N.I., Nichols T.E., Meyer P., Wernette K., Minoshima S., Kilbourn M.R., Frey K.A. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 2003, 61:310-315.
3. Azrin N.H., Peterson A.L. Habit reversal for the treatment of Tourette syndrome. Behaviour Research and Therapy 1988, 26:347-351.
4. Baldan Ramsey L.C., Williams K., Gallezot J., Crowley M., Anderson G., Leventhal B.L., Ohtsu H., Krystal J.H., Mayes L., de Araujo I., Ding Y., State M.W., Pittenger C. Histidine decarboxylase deficiency produces Tourette syndrome phenomenology and dopamine dysregulation in humans and mice. Neuropsychopharmacology 2011, 36:S198.
5. Baldan Ramsey L.C., Xu M., Wood N., Pittenger C. Lesions of the dorsomedial striatum disrupt prepulse inhibition. Neuroscience 2011, 180:222-228.
6. Barense M.D., Fox M.T., Baxter M.G. Aged rats are impaired on an attentional set-shifting task sensitive to medial frontal cortex damage in young rats. Learning and Memory 2002, 9:191-201.
7. Bargh J.A. The ecology of automaticity: toward establishing the conditions needed to produce automatic processing effects. American Journal of Psychology 1992, 105:181-199.
8. Bornstein R. Exposure and affect: overview and meta-analysis of research, 1968-1987. Psychological Bulletin 1989, 106:265-289.
9. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978, 15:339-343.
10. Busemeyer J.R., Townsend J.T. Decision field theory: a dynamic-cognitive approach to decision making in an uncertain environment. Psychological Review 1993, 100:432-459.
11. Campbell K.M., Veldman M.B., McGrath M.J., Burton F.H. TS+OCD-like neuropotentiated mice are supersensitive to seizure induction. NeuroReport 2000, 11:2335-2338.
12. Castellanos F.X., Fine E.J., Kaysen D., Marsh W.L., Rapoport J.L., Hallett M. Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biological Psychiatry 1996, 39:33-41.
13. Deckersbach T., Rauch S., Buhlmann U., Wilhelm S. Habit reversal versus supportive psychotherapy in Tourette's disorder: a randomized controlled trial and predictors of treatment response. Behaviour Research and Therapy 2006, 44:1079-1090.
14. Dénes J., Keedwell A.D. Latin Squares and Their Applications 1974, Academic Press, New York-London.
15. Elkins I.J., Cromwell R.L. Priming effects in schizophrenia: associative interference and facilitation as a function of visual context. Journal of Abnormal Psychology 1994, 103:791-800.
16. Graham F.K. Presidential Address, 1974. The more or less startling effects of weak prestimulation. Psychophysiology 1975, 12:238-248.
17. Granon S., Passetti F., Thomas K.L., Dalley J.W., Everitt B.J., Robbins T.W. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. Journal of Neuroscience 2000, 20:1208-1215.
18. Grilly D.M., Loveland A. What is a low dose of d-amphetamine for inducing behavioral effects in laboratory rats?. Psychopharmacology 2001, 153:155-169.
19. Hamidovic A., Dlugos A., Palmer A.A., de Wit H. Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine. Psychiatric Genetics 2010, 20:85-92.
20. Hartston H.J., Swerdlow N.R. Visuospatial priming and stroop performance in patients with obsessive compulsive disorder. Neuropsychology 1999, 13:447-457.
21. Kaneko H., Tamura H., Kawashima T., Suzuki S.S. A choice reaction-time task in the rat: a new model using air-puff stimuli and lever-release responses. Behavioural Brain Research 2006, 174:151-159.
22. Kay L.M., Beshel J., Martin C. When good enough is best. Neuron 2006, 51:277-278.
23. Ko T., Evenden J. The effects of psychotomimetic and putative cognitive-enhancing drugs on the performance of a n-back working memory task in rats. Psychopharmacology (Berl) 2009, 202:67-78.
24. Leckman J.F., Bloch M.H., Smith M.E., Larabi D., Hampson M. Neurobiological substrates of Tourette's disorder. Journal of Child and Adolescent Psychopharmacology 2010, 20:237-247.
25. Lyon M., Robbins T.W. The action of central nervous system stimulant drugs: a general theory concerning amphetamine effects. Current Developments in Psychopharmacology 1975, vol. 2:79-163. Spectrum, New York.
26. Mattay V.S., Goldberg T.E., Fera F., Hariri A.R., Tessitore A., Egan M.F., Kolachana B., Callicott J.H., Weinberger D.R. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:6186-6191.
27. Moghaddam B., Bunney B.S. Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: comparison to amphetamine. Synapse 1989, 4:156-161.
28. Ozonoff S., Strayer D.L., McMahon W.M., Filloux F. Inhibitory deficits in Tourette syndrome: a function of comorbidity and symptom severity. Journal of Child Psychology and Psychiatry 1998, 39:1109-1118.
29. Papaleo F., Crawley J.N., Song J., Lipska B.K., Pickel J., Weinberger D.R., Chen J. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. Journal of Neuroscience 2008, 28:8709-8723.
30. Paterson N.E., Ricciardi J., Wetzler C., Hanania T. Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone. Neuroscience Research 2011, 69:41-50.
31. Piacentini J., Woods D.W., Scahill L., Wilhelm S., Peterson A.L., Chang S., Ginsburg G.S., Deckersbach T., Dziura J., Levi-Pearl S., Walkup J.T. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA 2010, 303:1929-1937.
32. Rinberg D., Koulakov A., Gelperin A. Speed-accuracy tradeoff in olfaction. Neuron 2006, 51:351-358.
33. Swerdlow N.R., Bongiovanni M.J., Tochen L., Shoemaker J.M. Separable noradrenergic and dopaminergic regulation of prepulse inhibition in rats: implications for predictive validity and Tourette Syndrome. Psychopharmacology (Berl) 2006, 186:246-254.
34. Swerdlow N.R., Hartman P.L., Auerbach P.P. Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biological Psychiatry 1997, 41:452-460.
35. Swerdlow N.R., Karban B., Ploum Y., Sharp R., Geyer M.A., Eastvold A. Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an fMRI-friendly startle paradigm. Biological Psychiatry 2001, 50:578-585.
36. Swerdlow N.R., Magulac M., Filion D., Zinner S. Visuospatial priming and latent inhibition in children and adults with Tourette's disorder. Neuropsychology 1996, 10:485-494.
37. Swerdlow N.R., Sutherland A.N. Using animal models to develop therapeutics for Tourette syndrome. Pharmacology & Therapeutics 2005, 108:281-293.
38. Swerdlow N.R., Sutherland A.N. Preclinical models relevant to Tourette syndrome. Advances in Neurology 2006, 99:69-88.
39. Swerdlow N.R., Weber M., Qu Y., Light G.A., Braff D.L. Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) 2008, 199:331-388.
40. Talledo J.A., Sutherland Owens A.N., Schortinghuis T., Swerdlow N.R. Amphetamine effects on startle gating in normal women and female rats. Psychopharmacology (Berl) 2009, 204:165-175.
41. Tipper S.P. The negative priming effect: inhibitory priming by ignored objects. Quarterly Journal of Experimental Psychology. A, Human Experimental Psychology 1985, 37:571-590.
42. Tipper S.P. Does negative priming reflect inhibitory mechanisms? A review and integration of conflicting views. Quarterly Journal of Experimental Psychology. A, Human Experimental Psychology 2001, 54:321-343.
43. Tizabi Y., Russell L.T., Johnson M., Darmani N.A. Nicotine attenuates DOI-induced head-twitch response in mice: implications for Tourette syndrome. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2001, 25:1445-1457.
44. Tomporowski P.D., Tinsley V., Hager L.D. Visuospatial attentional shifts and choice responses of adults and ADHD and non-ADHD children. Perceptual and Motor Skills 1994, 79:1479-1490.
45. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002, 58:527-536. Tourette's Syndrome Study Group.
46. Uchida N., Mainen Z.F. Speed and accuracy of olfactory discrimination in the rat. Nature Neuroscience 2003, 6:1224-1229.
47. Wright C.I., Keuthen N.J., Savage C.R., Martis B., Williams D., Wedig M., McMullin K., Rauch S.L. Brain correlates of negative and positive visuospatial priming in adults. Neuroimage 2006, 30:983-991.
48. Wright C.I., McMullin K., Martis B., Fischer H., Rauch S.L. Brain correlates of negative visuospatial priming in healthy children. Psychiatry Research 2005, 139:41-52.
49. Wylie S.A., Stout J.C. Enhanced negative priming in Parkinson's disease. Neuropsychology 2002, 16:242-250.
50. Yamaguchi S., Kobayashi S. Contributions of the dopaminergic system to voluntary and automatic orienting of visuospatial attention. Journal of Neuroscience 1998, 18:1869-1878.
51. Young J.W., Powell S.B., Geyer M.A., Jeste D.V., Risbrough V.B. The mouse attentional-set-shifting task: a method for assaying successful cognitive aging?. Cognitive, Affective, & Behavioral Neuroscience 2010, 10:243-251.